Seattle and Daiichi Sankyo at each other's throats; UC Berkeley, UCSF and the University of Washington launch Weill Neurohub
→ Seattle Genetics and Daiichi Sankyo — once partners — are now bitter foes battling over intellectual property underpinning ADC technology. After going their separate ways …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
